Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-12-05
2006-12-05
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S144000
Reexamination Certificate
active
07144901
ABSTRACT:
An oxadiazole derivative of formula (I) and a non-toxic salt thereof,wherein R is hydrogen, alkyl, CycA, etc.; AA1is a single bond, amino acid residue, etc.; AA2is a single bond, amino acid residue, etc.; R7and R8are hydrogen, alkyl, etc.; R9is hydrogen, alkyl, etc. R10is hydrogen, alkyl, etc.).
REFERENCES:
patent: 2004/0204368 (2004-10-01), Ohmoto
patent: 1 234 821 (2002-08-01), None
patent: 1 254 901 (2002-11-01), None
patent: WO 99/54317 (1999-10-01), None
patent: WO 00/01666 (2000-01-01), None
Todd L. Graybill, et al., “Synthesis and Evaluation of Diacylhydrazines as Inhibitors of the Interleukin-1β Converting Enzyme (ICE),” Bioorganic & Medicinal Chemistry Letters, 1995, pp. 1197-1202, vol. 5, No. 11.
Itagaki Iori
Ohmoto Kazuyuki
Anderson Rebecca
ONO Pharmaceutical Co.,Ltd.
Saeed Kamal A.
Sughrue & Mion, PLLC
LandOfFree
Oxadiazole derivatives and drugs containing these... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxadiazole derivatives and drugs containing these..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxadiazole derivatives and drugs containing these... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3678172